InsidersTradesSigma
Follow the SOMNOMED LIMITED share price and the full management transaction log of the company, a publicly traded company based in Australia. Shares trade on the AU market, under the authority of ASX. Market capitalisation: €73.6m. The latest transaction was reported on 27 July 2026 (Other). Among the most active insiders: Amrita Singh Blickstead. Every trade is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
SOMNOMED LIMITED is a company focused on developing medical devices for the treatment of sleep disorders, particularly sleep apnea. It is listed on the XASX market.